At 0 2 0 2 O
least 3 8 3 8 O
18 9 11 9 11 B-lower_bound
years 12 17 12 17 I-lower_bound
of 18 20 18 20 O
age 21 24 21 24 B-age

Females 0 7 25 32 B-gender
who 8 11 33 36 O
are 12 15 37 40 O
pregnant 16 24 41 49 B-pregnancy
at 25 27 50 52 O
the 28 31 53 56 O
time 32 36 57 61 O
of 37 39 62 64 O
screening 40 49 65 74 O
will 50 54 75 79 O
not 55 58 80 83 O
be 59 61 84 86 O
eligible 62 70 87 95 O
for 71 74 96 99 O
this 75 79 100 104 O
study 80 85 105 110 O
, 85 86 110 111 O
urine 87 92 112 117 B-pregnancy
pregnancy 93 102 118 127 I-pregnancy
test 103 107 128 132 O
will 108 112 133 137 O
be 113 115 138 140 O
performed 116 125 141 150 O
at 126 128 151 153 O
screening 129 138 154 163 O
in 139 141 164 166 O
women 142 147 167 172 B-gender
of 148 150 173 175 O
child 151 156 176 181 O
- 156 157 181 182 O
bearing 157 164 182 189 O
potential 165 174 190 199 O

History 0 7 200 207 O
of 8 10 208 210 O
histologically 11 25 211 225 O
or 26 28 226 228 O
cytologically 29 42 229 242 O
confirmed 43 52 243 252 O
breast 53 59 253 259 B-cancer
cancer 60 66 260 266 I-cancer
, 66 67 266 267 O
any 68 71 268 271 O
ER 72 74 272 274 B-clinical_variable
, 74 75 274 275 O
PR 76 78 276 278 B-clinical_variable
or 79 81 279 281 O
HER2 82 86 282 286 B-clinical_variable
status 87 93 287 293 O
is 94 96 294 296 O
allowed 97 104 297 304 O
as 105 107 305 307 O
long 108 112 308 312 O
as 113 115 313 315 O
it 116 118 316 318 O
expresses 119 128 319 328 O
the 129 132 329 332 O
Rb 133 135 333 335 B-clinical_variable
protein 136 143 336 343 I-clinical_variable

Patients 0 8 344 352 O
must 9 13 353 357 O
be 14 16 358 360 O
candidates 17 27 361 371 O
to 28 30 372 374 O
receive 31 38 375 382 O
treatment 39 48 383 392 B-treatment
on 49 51 393 395 O
the 52 55 396 399 O
therapeutic 56 67 400 411 B-treatment
trial 68 73 412 417 I-treatment
UPCC06115 74 83 418 427 I-treatment
, 83 84 427 428 O
a 85 86 429 430 O
Phase 87 92 431 436 O
I 93 94 437 438 O
study 95 100 439 444 O
of 101 103 445 447 O
ribociclib 104 114 448 458 O
( 115 116 459 460 O
LEE011 116 122 460 466 O
) 122 123 466 467 O
and 124 127 468 471 O
weekly 128 134 472 478 O
paclitaxel 135 145 479 489 B-treatment

Serious 0 7 490 497 B-chronic_disease
or 8 10 498 500 O
unstable 11 19 501 509 O
medical 20 27 510 517 O
or 28 30 518 520 O
psychological 31 44 521 534 B-chronic_disease
conditions 45 55 535 545 I-chronic_disease
that 56 60 546 550 O
, 60 61 550 551 O
in 62 64 552 554 O
the 65 68 555 558 O
opinion 69 76 559 566 O
of 77 79 567 569 O
the 80 83 570 573 O
investigator 84 96 574 586 O
, 96 97 586 587 O
would 98 103 588 593 O
compromise 104 114 594 604 O
the 115 118 605 608 O
subject 119 126 609 616 O
's 126 128 616 618 O
safety 129 135 619 625 O
or 136 138 626 628 O
successful 139 149 629 639 O
participation 150 163 640 653 O
in 164 166 654 656 O
the 167 170 657 660 O
study 171 176 661 666 O

